ECKERT & ZIEGLER SE (EUZ.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:EUZ - DE0005659700 - Common Stock
EUZ.DE Key Statistics, Chart & Performance
The current stock price of EUZ.DE is 16.32 EUR. In the past month the price increased by 5.49%. In the past year, price decreased by -32.51%.
EUZ.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.67 | 109.18B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.46 | 52.46B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.17 | 24.47B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.18 | 24.49B | ||
| BIM.PA | BIOMERIEUX | 29.25 | 13.36B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 150 | 4.51B | ||
| DIA.MI | DIASORIN SPA | 21.93 | 4.06B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.63 | 3.69B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 11.66 | 1.41B | ||
| ELN.MI | EL.EN. SPA | 22.86 | 1.18B | ||
| DRW8.DE | DRAEGERWERK AG | 9.55 | 1.16B | ||
| GVS.MI | GVS SPA | 45.83 | 780.37M |
Related stock screener links
About EUZ.DE
Company Profile
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,112 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Company Info
ECKERT & ZIEGLER SE
Robert-Roessle-Str.10
Berlin BERLIN DE
Employees: 1112
Phone: 49309410840
ECKERT & ZIEGLER SE / EUZ.DE FAQ
What does EUZ do?
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,112 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Can you provide the latest stock price for ECKERT & ZIEGLER SE?
The current stock price of EUZ.DE is 16.32 EUR. The price increased by 5.91% in the last trading session.
What is the dividend status of ECKERT & ZIEGLER SE?
ECKERT & ZIEGLER SE (EUZ.DE) has a dividend yield of 1.09%. The yearly dividend amount is currently 0.02.
How is the ChartMill rating for ECKERT & ZIEGLER SE?
EUZ.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Which stock exchange lists EUZ stock?
EUZ.DE stock is listed on the Frankfurt Stock Exchange exchange.
Can you provide the sector and industry classification for ECKERT & ZIEGLER SE?
ECKERT & ZIEGLER SE (EUZ.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
EUZ.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to EUZ.DE. When comparing the yearly performance of all stocks, EUZ.DE is a bad performer in the overall market: 90.8% of all stocks are doing better.
EUZ.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE. EUZ.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
EUZ.DE Financial Highlights
Over the last trailing twelve months EUZ.DE reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 43.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.06% | ||
| ROA | 8.79% | ||
| ROE | 17.17% | ||
| Debt/Equity | 0.16 |
EUZ.DE Forecast & Estimates
7 analysts have analysed EUZ.DE and the average price target is 21.73 EUR. This implies a price increase of 33.12% is expected in the next year compared to the current price of 16.32.
For the next year, analysts expect an EPS growth of 54.21% and a revenue growth 8.58% for EUZ.DE